Tumor mutation burden (TMB) had weak positive correlations only with CD274 (p = 0.01342; R = 0.127), CXCL9 (p = 0.038; R = 0.1078), and also with the XP cluster 2 genes ERCC3 (p = 0.00196; R = 0.157) and ERCC2 (p = 0.027; R = 0.114). This evidence concerns the gene CD274 and neoplasm.